Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TAK-536 and Pioglitazone in Type 2 Diabetes
NCT00376181Phase 3Terminated
- Sponsor
- Takeda
- Start
- Jun 2006
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of azilsartan in type 2 diabetes mellitus (T2DM), hypertension (HTN), sponsored by Takeda. Started Jun 2006; status: terminated.
02
Drugs
azilsartan
03
Conditions
type 2 diabetes mellitus (T2DM)hypertension (HTN)
Beyond the preview
Go deeper on NCT00376181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00376181.